This Volume Table of Contents Description This Article Full Text Full Text (PDF) Services Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by KINO, T. Articles by CHROUSOS, G. P. Search for Related Content PubMed PubMed Citation Articles by KINO, T. Articles by CHROUSOS, G. P.

Annals of the New York Academy of Sciences 970:101-111 (2002)
© 2002 New York Academy of Sciences

Familial/Sporadic Glucocorticoid Resistance Syndrome and Hypertension

Glucocorticoids regulate diverse functions important for the maintenance of central nervous system, cardiovascular, metabolic, and immune homeostasis. The actions of these hormones are mediated by the specific intracellular glucocorticoid receptors (GRs). Pathologic conditions associated with changes of tissue sensitivity to these hormones have been described. The syndrome of familial/sporadic glucocorticoid resistance is characterized by hypercortisolism without Cushing syndrome stigmata. Many of the patients present with hypertension, with or without hypokalemic alkalosis, as a result of elevated concentrations of cortisol and other salt-retaining steroids. The molecular defects of 4 kindreds and one sporadic case have been elucidated as inactivating mutations in the ligand-binding domain of the GR. In two patients in whom the GR was mutated at amino acid isoleucine 559 to aspartic acid (GRI559N) and isoleucine 747 to methionine (GRI747M), respectively, glucocorticoid resistance developed at the heterozygous state, with transdominant negative activity of each of the mutant receptors upon the wild-type protein. Retention of the wild-type receptor in the cytoplasm by the mutant receptor was found in the former, while inappropriate accumulation of p160-type coactivators on the promoter region of glucocorticoid-responsive genes, because of a defective interaction between the AF2 region of the mutant receptor and the LXXLL motif of the coactivators, was determined in the latter. These results suggest that the pathologic mechanisms of glucocorticoid resistance is quite broad, and this is reflected in the wide variability of the clinical picture in patients with the syndrome.

This article has been cited by other articles:

				E. Charmandari, T. Kino, T. Ichijo, and G. P. Chrousos Generalized Glucocorticoid Resistance: Clinical Aspects, Molecular Mechanisms, and Implications of a Rare Genetic Disorder J. Clin. Endocrinol. Metab., May 1, 2008; 93(5): 1563 - 1572. [Abstract] [Full Text] [PDF]

				H. Raef, E. Y Baitei, M. Zou, and Y. Shi Genotype-phenotype correlation in a family with primary cortisol resistance: possible modulating effect of the ER22/23EK polymorphism. Eur. J. Endocrinol., April 1, 2008; 158(4): 577 - 582. [Abstract] [Full Text] [PDF]

				E. Charmandari, T. Kino, T. Ichijo, W. Jubiz, L. Mejia, K. Zachman, and G. P. Chrousos A Novel Point Mutation in Helix 11 of the Ligand-Binding Domain of the Human Glucocorticoid Receptor Gene Causing Generalized Glucocorticoid Resistance J. Clin. Endocrinol. Metab., October 1, 2007; 92(10): 3986 - 3990. [Abstract] [Full Text] [PDF]

				E. Charmandari, T. Kino, T. Ichijo, K. Zachman, A. Alatsatianos, and G. P. Chrousos Functional Characterization of the Natural Human Glucocorticoid Receptor (hGR) Mutants hGR{alpha}R477H and hGR{alpha}G679S Associated with Generalized Glucocorticoid Resistance J. Clin. Endocrinol. Metab., April 1, 2006; 91(4): 1535 - 1543. [Abstract] [Full Text] [PDF]

				O. Fruchter, T. Kino, E. Zoumakis, S. Alesci, M. De Martino, G. Chrousos, and Z. Hochberg The Human Glucocorticoid Receptor (GR) Isoform {beta} Differentially Suppresses GR{alpha}-Induced Transactivation Stimulated by Synthetic Glucocorticoids J. Clin. Endocrinol. Metab., June 1, 2005; 90(6): 3505 - 3509. [Abstract] [Full Text] [PDF]

				E. Charmandari, A. Raji, T. Kino, T. Ichijo, A. Tiulpakov, K. Zachman, and G. P. Chrousos A Novel Point Mutation in the Ligand-Binding Domain (LBD) of the Human Glucocorticoid Receptor (hGR) Causing Generalized Glucocorticoid Resistance: The Importance of the C Terminus of hGR LBD in Conferring Transactivational Activity J. Clin. Endocrinol. Metab., June 1, 2005; 90(6): 3696 - 3705. [Abstract] [Full Text] [PDF]

				S. M. Gold, I. Dziobek, K. Rogers, A. Bayoumy, P. F. McHugh, and A. Convit Hypertension and Hypothalamo-Pituitary-Adrenal Axis Hyperactivity Affect Frontal Lobe Integrity J. Clin. Endocrinol. Metab., June 1, 2005; 90(6): 3262 - 3267. [Abstract] [Full Text] [PDF]

				E. CHARMANDARI, T. KINO, and G. P. CHROUSOS Glucocorticoids and Their Actions: An Introduction Ann. N.Y. Acad. Sci., June 1, 2004; 1024(1): 1 - 8. [Full Text] [PDF]

				M. U. DE MARTINO, S. ALESCI, G. P. CHROUSOS, and T. KINO Interaction of the Glucocorticoid Receptor and the Chicken Ovalbumin Upstream Promoter-Transcription Factor II (COUP-TFII): Implications for the Actions of Glucocorticoids on Glucose, Lipoprotein, and Xenobiotic Metabolism Ann. N.Y. Acad. Sci., June 1, 2004; 1024(1): 72 - 85. [Abstract] [Full Text] [PDF]

				E. CHARMANDARI, T. KINO, and G. P. CHROUSOS Familial/Sporadic Glucocorticoid Resistance: Clinical Phenotype and Molecular Mechanisms Ann. N.Y. Acad. Sci., June 1, 2004; 1024(1): 168 - 181. [Abstract] [Full Text] [PDF]

				E. Charmandari, T. Kino, E. Souvatzoglou, A. Vottero, N. Bhattacharyya, and G. P. Chrousos Natural Glucocorticoid Receptor Mutants Causing Generalized Glucocorticoid Resistance: Molecular Genotype, Genetic Transmission, and Clinical Phenotype J. Clin. Endocrinol. Metab., April 1, 2004; 89(4): 1939 - 1949. [Abstract] [Full Text] [PDF]